Since the outbreak of the COVID-19 pandemic and its rapid spread, the scientific community has been working on developing an effective treatment for the virus responsible for the disease.
A study by University of Cincinnati researchers and four Italian institutions reviewing neuroimaging and neurological symptoms in patients with COVID-19 may shed light on the virus's impact on the central nervous system.
Now and in the months to come, hospitals and commercial buildings will be tasked with sanitizing large indoor environments to prevent the transmission of viruses like SARS-CoV-2, which causes COVID-19. A new seed grant-funded study could provide the knowledge base needed to develop optical radiation products used in such large-scale sanitation processes.
While scientists around the world search for a coronavirus vaccine, an equivalent effort should be made to develop drugs that would mitigate the virus’s effects on patients, says Johns Hopkins Carey Business School Senior Lecturer Bonnie Robeson, who previously served as a principal investigator in drug discovery and development at the National Cancer Institute.
This release concerns conclusive results from a research project that was put together to model the potential spread of coronavirus through air particles in indoor public spaces such as supermarkets (https://www.aalto.fi/en/news/researchers-modelling-the-spread-of-the-coronavirus-emphasise-the-importance-of-avoiding-busy)
In the face of dwindling supplies of virus transport media, cheap and readily available phosphate buffered saline can be used to safely store and transport coronavirus samples for up to 18 hours, reports The Journal of Molecular Diagnostics
New research from the Perelman School of Medicine at the University of Pennsylvania catalogued every use documented in medical literature so far and found physicians have reported on the use of more than 100 different off-label and experimental treatments
WASHINGTON, DC (May 27. 2020) – The George Washington University Milken Institute School of Public Health (Milken Institute SPH) today announced a new grant from the National Aeronautics and Space Administration (NASA) to study the impact of COVID-19 social distancing measures on the air quality in cities around the world. The project, which NASA announced earlier this month, will evaluate how air pollution has changed after schools and business shut down in order to contain the spread of the virus.
A three-pronged approach will help to predict COVID-19 infection in healthcare workers. At the center of it all – a ring, which tracks vitals such as heart rate and temperature and alerts the user that they might be getting sick without even realizing it. The study also will determine if participants go on to develop an acute COVID-19 infection and the prevalence rate in that population. Researchers hope to better identify patterns that could predict the emergence and recovery from novel infections to prevent and contain future pandemics.
In a new paper published online in the Annals of the American Thoracic Society, researchers have been unable to produce two theorized subphenotypes of COVID-19 related acute respiratory distress syndrome (ARDS). Scientists previously proposed that two phenotypes exist that differentiate patients with more severe COVID-19 and indicate that they should be treated differently. A phenotype is a set of characteristics used to classify a patient, which may influence disease management.
Having a faulty gene linked to dementia doubles the risk of developing severe COVID-19, according to a large-scale study.
University of North Carolina School of Medicine researchers designed experiments using gene-editing tools to discover how molecules called gangliosides serve as de facto gatekeepers to allow hepatitis A virus entry into liver cells.
The investigational antiviral remdesivir is superior to the standard of care for the treatment of COVID-19, according to a report published today in The New England Journal of Medicine.
Early in the pandemic, American Indian Reservations have experienced a disproportionately high incidence of COVID-19 infections: four times higher than in the US population, reports a study in the July/August issue of the Journal of Public Health Management and Practice. The special issue of JPHMP focuses on COVID-19, with commentaries and scientific articles describing the pandemic in the United States and globally. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Even after heroic medical and societal efforts finally break the back of the current COVID-19 pandemic, the global sigh of relief may not last long. The chilling reality is that viral threats are growing more common. And they’re getting deadlier.
A $1 million gift from the Shurl and Kay Curci Foundation will support the UCLA COVID-19 Rapid Response Initiative, a partnership of the UCLA Fielding School of Public Health and the David Geffen School of Medicine at UCLA.
UC San Diego Health has deployed a mobile ECMO life support system to help sustain critically-ill patients during the pandemic.
The commercialization of a Cornell-created antimicrobial coating technology that keeps surfaces clean by extending the life of chlorine-based disinfectants – by days and even weeks – is being fast-tracked to determine how well it can combat COVID-19.
Hackensack Meridian Health researchers have treated 1,000 patients as part of 10 clinical trials in response to the COVID-19 pandemic.
A team of investigators at NYU Langone Health determined that just over half of 5,279 patients who tested positive for COVID-19 were hospitalized -- and nearly a quarter of those hospitalized died or were discharged to hospice, including 60 percent who required ventilators.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right